Trial Profile
A phase 2 study of SENS-218 in patients with Vestibular lessions
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 24 Aug 2015
Price :
$35
*
At a glance
- Drugs SENS 218 (Primary)
- Indications Ear disorders
- Focus Therapeutic Use
- 24 Aug 2015 New trial record